14 Jan Exact Sciences is No. 1 gainer among Wisconsin stocks in 2017
As the stock market climbed to record heights for a second straight year, more Wisconsin stocks went up than down in 2017.
But no percentage increase was anywhere near as big as that of Exact Sciences Corp.
Shares of the Madison company — whose Cologuard home test kit screens for colorectal cancer — soared as high as $63.60 in November, nearly five times their closing price of $13.36 on Dec. 31, 2016. The stock ended 2017 at $52.54, still a 293 percent increase from a year ago.
With Cologuard use continuing to expand, and tests in the works to find several other types of cancer, Exact is “the most intriguing diagnostic company in the market at this time,” analyst Brian Weinstein, with the William Blair investment firm, wrote in a research note Monday.
Sorry, the comment form is closed at this time.